Search Results - "Amerigo Góngora, Marta"
-
1
Targeted axillary dissection in breast cancer by marking lymph node metastasis with a magnetic seed before starting neoadjuvant treatment
Published in Journal of surgical case reports (01-11-2019)“…Abstract We report the first documented clinical case of the use of magnetic seeds to mark axillary lymph node metastasis in breast cancer before neoadjuvant…”
Get full text
Journal Article -
2
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study
Published in Clinical & translational oncology (01-09-2024)“…Purpose HER2-targeted therapies have dramatically improved outcomes of patients with HER2-positive breast cancer (BC), as demonstrated in neoadjuvant trials…”
Get full text
Journal Article -
3
Unveiling the relationship between the UGT2B gene family and neoadjuvant treatment response in patients with HER2-positive breast cancer
Published in Journal of clinical oncology (01-06-2024)“…e12651 Background: Achieving a pathological complete response (pCR) following neoadjuvant treatment (NAT) in HER2-positive tumors significantly enhances…”
Get full text
Journal Article -
4
Different pCR rates according PAM50 defined subtypes in HER2 positive early breast cancer treated with neoadjuvant pertuzumab and trastuzumab
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
Leiomyo-adenomatoid tumor of the uterus: a distinct morphological entity?
Published in Archives of gynecology and obstetrics (01-10-2010)“…Introduction The morphologic and immunohistochemical findings of a well-circumscribed leiomyoadenomatoid tumor located in the posterior uterine wall are…”
Get full text
Journal Article -
6
Abstract P1-18-29: Neopersur: Neoadjuvant pertuzumab in a real world data population in the south of Spain
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Background: Pertuzumab (P) has been aproved in neoadjuvant setting for HER2 positive early breasta cancer patients in association with Trastuzumab (T) and…”
Get full text
Journal Article -
7